Indigo Paints Limited (INDIGOPNTS)
Analysts/Institutional Investor Meet/Con. Call Updates
AI summary
- Q2 FY27 standalone revenue grew 14.1% y-y to INR340.5 Cr; EBITDA margin fell to 8.9% from 15.3% due to raw material cost shock
- Raw material prices doubled in Mar-Apr 2026 due to Iran war, causing inventory cost inflation impacting Q2 margins
- H1 FY27 standalone revenue up 16.4%, EBITDA margin declined to 13.4% from 15.1%; PAT margin at 8.0%
- Volume growth strong across categories; emulsions volume up 10.4%, primers 9.4%
- New water-based plant at Jodhpur trial production started Sep 2026; full capacity expected by Dec 2026
- Gross and EBITDA margins expected to normalize from Q3 onwards with price hikes implemented
- Distribution network expanded to 19,730 dealers; brand building and influencer engagement ongoing
- Capacity utilization averages ~60%; no major capex planned for next 2-3 years
- Management cautious on geopolitical risks but confident of improved H2 growth and margins
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 INDIGOPNTS — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add INDIGOPNTS to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Indigo Paints Limited
Important.
The summary above is generated automatically from Indigo Paints Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.